focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Change of Adviser

1 Dec 2010 07:00

RNS Number : 1254X
Surgical Innovations Group PLC
01 December 2010
Ā 

ļ»æ

01 December 2010

Ā 

Surgical Innovations Group plc

Change of Adviser

Ā 

Surgical Innovations Group plc (AIM:SUN), the designer and manufacturer of innovative medical devices, is pleased to announce the appointment of Seymour Pierce Limited as its Nominated Adviser and Broker, with immediate effect.

- Ends -

Enquiries:

Surgical Innovations Group plc

Doug Liversidge, Non-Executive Chairman

Graham Bowland, Chief Executive Officer

Tel: +44 (0) 113 230 7597

graham.bowland@surginno.co.uk

www.surginno.com

Ā 

Seymour Pierce Limited (Nominated Adviser)

Freddy Crossley

Tel: +44 (0) 20 7107 8000

Sarah Jacobs

Corporate Broking

Marianne Woods

www.seymourpierce.com

Ā 

Media enquiries:The Communications Portfolio

Ariane Comstiveariane.comstive@communications-portfolio.co.uk

Tel: +44 (0) 20 7536 2028

Mob: +44 (0) 7785 922 354

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets. The Group's main focus is on developing medical instruments for the laparoscopic surgery market - minimally invasive surgery of the abdomen.

Surgical Innovations has pioneered ResposableĀ® instrumentation combining both single use and reusable components ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

Through an established network of 45 distribution partners, SI sells in all major medical markets including North America, Europe, South Africa, the Middle East, South-East Asia and Australia. The Group's strategy is to sell its own branded instruments as well as to license its IP to large medical device companies including Teleflex Medical, Gyrus, Olympus and CareFusion.

The Group's products include:

Ā YelloPort+plusĀ®

A resposableĀ® laparoscopic port access system that combines both single-use and reusable components

LogiĀ®Range

resposableĀ® laparoscopic instrumentation that combines both single-use and reusable components

QuickĀ®Range

single-use instruments, with an ergonomic handle to ensure accurate control of the instrument. The range includes scissors, graspers and dissectors

Ā 

The Group employs over 100 people at its 32,000 square feet facility in Leeds, with in-house design and the manufacturing of products to the highest quality standards.

For more information, see www.surginno.com

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
APPKMMFMGGZGGZZ

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.